5,611
Views
35
CrossRef citations to date
0
Altmetric
State-of-the-Art Review

Management of staghorn renal stones

&
Pages 357-362 | Received 08 Nov 2017, Accepted 15 Mar 2018, Published online: 16 Apr 2018

References

  • Healy KA, Ogan K. Pathophysiology and management of infectious staghorn calculi. Urol Clin North Am. 2007;34:363–374.
  • Preminger GM, Assimos DG, Lingeman JE, et al. Chapter 1: AUA guideline on management of staghorn calculi: diagnosis and treatment recommendations. J Urol. 2005;173:1991–2000.
  • Rieu P. [Infective lithiasis]. Ann Urol (Paris). 2005;39:16–29.
  • Johnson CM, Wilson DM, O’Fallon WM, et al. Renal stone epidemiology: a 25 year study in Rochester, Minnesota. Kidney Int. 1979;16:624–631.
  • Hiatt RA, Dales LG, Friedman GD, et al. Frequency of urolithiasis in a prepaid medical care program. Am J Epidemiol. 1982;115:255–265.
  • Vargas AD, Bragin SD, Mendez R. Staghorn calculis: its clinical presentation, complications and management. J Urol. 1982;127:860–862.
  • Teichman JMH, Long RD, Hulbert JC. Long-term renal fate and prognosis after staghorn calculus management. J Urol. 1995;153:1403–1407.
  • Buchholz NP, Abbas F, Afzal M, et al. The prevalence of silent kidney stones-an ultrasonographic screening study. J Pak Med Assoc. 2003;53:24–25.
  • Resnick MI, Boyce WH. Bilateral staghorn calculi-patient evaluation and management. J Urol. 1980;123:338–341.
  • Viprakasit DP, Sawyer MD, Herrell SD, et al. Changing composition of staghorn calculi. J Urol. 2011;186:2285–2290.
  • Heimbach D, Jacobs D, Muller SC, et al. Chemolitholysis and lithotripsy of infectious urinary stones – an in vitro study. Urol Int. 2002;69:212–218.
  • Blandy JP, Singh M. The case for a more aggressive approach to staghorn stones. J Urol. 1976;115:505–506.
  • Koga S, Arakaki Y, Matsuoka M, et al. Staghorn calculi-long-term results of management. Br J Urol. 1991;68:122–124.
  • Hesse A, Heimbach D. Causes of phosphate stone formation and the importance of metaphylaxis by urinary acidification: a review. World J Urol. 1999;17:308–315.
  • Bichler KH, Eipper E, Naber K, et al. Urinary infection stones. Int J Antimicrob Agents. 2002;19:488–498.
  • Gettman MT, Segura JW. Struvite stones: diagnosis and current treatment concepts. J Endourol. 1999;13:653–658.
  • Parks JH, Worcester EM, Coe FL, et al. Clinical implications of abundant calcium phosphate in routinely analyzed kidney stones. Kidney Int. 2004;66:777–785.
  • Abate N, Chandalia M, Cabo-Chan AV Jr, et al. The metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance. Kidney Int. 2004;65:386–392.
  • Kristensen C, Parks JH, Lindheimer M, et al. Reduced glomerular filtration rate and hypercalciuria in primary struvite nephrolithiasis. Kidney Int. 1987;32:749–753.
  • Segura JW. Staghorn calculi. Urol Clin North Am. 1997;24:71–80.
  • Deutsch PG, Subramonian K. Conservative management of staghorn calculi: a single-centre experience. BJU Int. 2016;118:444–450.
  • Türk C, Knoll T, Petrik A, et al. EAU Guidelines on Urolithiasis. Arnhem: European Association of Urology; 2016.
  • Clayman RV, Surya V, Miller RP, et al. Percutaneous nephrolithotomy. An approach to branched and staghorn renal calculi. JAMA. 1983;250:73–75.
  • Chibber PJ. Percutaneous nephrolithotomy for large and staghorn calculi. J Endourol. 1993;7:293–295.
  • Meretyk S, Gofrit ON, Gafni O, et al. Complete staghorn calculi: random prospective comparison between extracorporeal shock wave lithotripsy monotherapy and combined with percutaneous nephrostolithotomy. J Urol. 1997;157:780–786.
  • Desai M, Sun Y, Buchholz N, et al. Treatment selection for urolithiasis: percutaneous nephrolithotomy, ureteroscopy, shock wave lithotripsy, and active monitoring. World J Urol. 2017;35:1395–1397.
  • Al-Kohlany KM, Shokeir AA, Mosbah A, et al. Treatment of complete staghorn stones: a prospective randomized comparison of open surgery versus percutaneous nephrolithotomy. J Urol. 2005;173:469–473.
  • Wong C, Leveillee RJ. Single upper-pole percutaneous access for treatment of > or =5-cm complex branched staghorn calculi: is shockwave lithotripsy necessary? J Endourol. 2002;16:477–481.
  • Aron M, Yadav R, Goel R, et al. Multi-tract percutaneous nephrolithotomy for large complete staghorn calculi. Urol Int. 2005;75:327–332.
  • Zhao Z, Cui Z, Zeng T, et al. Comparison of 1-stage with 2-stage multiple-tracts mini-percutaneous nephrolithotomy for the treatment of staghorn stones: a matched cohorts analysis. Urology. 2016;87:46–51.
  • Zeng G, Zhao Z, Wan S, et al. Minimally invasive percutaneous nephrolithotomy for simple and complex renal caliceal stones: a comparative analysis of more than 10,000 cases. J Endourol. 2013;27:1203–1208.
  • El-Nahas AR, Elshal AM, El-Tabey NA, et al. Percutaneous nephrolithotomy for staghorn stones: a randomised trial comparing high-power holmium laser versus ultrasonic lithotripsy. BJU Int. 2016;118:307–312.
  • Marguet CG, Springhart WP, Tan YH, et al. Simultaneous combined use of flexible ureteroscopy and percutaneous nephrolithotomy to reduce the number of access tracts in the management of complex renal calculi. BJU Int. 2005;96:1097–1100.
  • Landman J, Venkatesh R, Lee DI, et al. Combined percutaneous and retrograde approach to staghorn calculi with application of the ureteral access sheath to facilitate percutaneous nephrolithotomy. J Urol. 2003;169:64–67.
  • Gleeson MJ, Griffith DP. Extracorporeal shockwave lithotripsy monotherapy for large renal calculi. Br J Urol. 1989;64:329–332.
  • El-Assmy A, El-Nahas AR, Madbouly K, et al. Extracorporeal shock-wave lithotripsy monotherapy of partial staghorn calculi. Prognostic factors and long-term results. Scand J Urol Nephrol. 2006;40:320–325.
  • Streem SB, Yost A, Dolmatch B. Combination “sandwich” therapy for extensive renal calculi in 100 consecutive patients: immediate, long-term and stratified results from a 10-year experience. J Urol. 1997;158:342–345.
  • Merhej S, Jabbour M, Samaha E, et al. Treatment of staghorn calculi by percutaneous nephrolithotomy and SWL: the Hotel Dieu de France experience. J Endourol. 1998;12:5–8.
  • Smith M, Boyce WH. Anatrophic nephrotomy and plastic calyrhaphy. J Urol. 1968;99:521–527.
  • Lam HS, Lingeman JE, Barron M, et al. Staghorn calculi: analysis of treatment results between initial percutaneous nephrostolithotomy and extracorporeal shock wave lithotripsy monotherapy with reference to surface area. J Urol. 1992;147:1219–1225.
  • Dretler SP, Pfister RC. Percutaneous dissolution of renal calculi. Annu Rev Med. 1983;34:359–366.
  • Bernardo NO, Smith AD. Chemolysis of urinary calculi. Urol Clin North Am. 2000;27:355–365.
  • Tiselius HG, Hellgren E, Andersson A, et al. Minimally invasive treatment of infection staghorn stones with shock wave lithotripsy and chemolysis. Scand J Urol Nephrol. 1999;33:286–290.
  • Shorr E, Carter AC. Aluminum gels in the management of renal phosphatic calculi. JAMA. 1950;144:1549–1556.
  • Lavengood RW Jr, Marshall VF. The prevention of renal phosphatic calculi in the presence of infection by the Shorr regimen. J Urol.1972;108:368–371.
  • Schwartz BF, Stoller ML. Nonsurgical management of infection-related renal calculi. Urol Clin North Am. 1999;26:765–778.
  • Martinez-Pineiro JA, de Iriarte EG, Armero AH. The problem of recurrences and infection after surgical removal of staghorn calculi. Eur Urol. 1982;8:94–101.
  • Beck EM, Riehle Jr RA. The fate of residual fragments after extracorporeal shock wave lithotripsy monotherapy of infection stones. J Urol. 1991;145:6–10.
  • Parkhomenko E, De Fazio A, Tran T, et al. A multi-institutional study of struvite stones: patterns of infection and colonization. J Endourol. 2017;31:533–537.